SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062098
Filing Date
2023-11-09
Accepted
2023-11-09 16:20:33
Documents
70
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vtyx-20230930.htm   iXBRL 10-Q 3106930
2 EX-31.1 vtyx-ex31_1.htm EX-31.1 20031
3 EX-31.2 vtyx-ex31_2.htm EX-31.2 20050
4 EX-32.1 vtyx-ex32_1.htm EX-32.1 11850
5 EX-32.2 vtyx-ex32_2.htm EX-32.2 11873
  Complete submission text file 0000950170-23-062098.txt   10796761

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtyx-20230930_pre.xml EX-101.PRE 398265
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtyx-20230930.xsd EX-101.SCH 57032
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtyx-20230930_cal.xml EX-101.CAL 51080
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtyx-20230930_def.xml EX-101.DEF 262364
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtyx-20230930_lab.xml EX-101.LAB 501167
64 EXTRACTED XBRL INSTANCE DOCUMENT vtyx-20230930_htm.xml XML 2087700
Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Filer) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40928 | Film No.: 231392808
SIC: 2834 Pharmaceutical Preparations